Top Markets
#1 Black Phoenix Black Phoenix +21,343.58%
#2 Nesa Nesa +790.76%
#3 Cortex Cortex +67.85%
#4 Kinesis Silver Kinesis Silver +55.16%
#5 QuantixAI QuantixAI +23.76%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +17.47%
#8 Bless Bless +14.29%
#9 Derive Derive +14.05%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +13.66%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Rang in Aktien #19185
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Aktienkurs
$4.62
Zuletzt synchronisiert: 2023-03-23
Marktkapitalisierung
$171.76M
Veränderung (1 Tag)
-37.16%
Veränderung (1 Jahr)
0.00%
Land
KR
Handel Cellivery Therapeutics, Inc. (268600)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Cellivery Therapeutics, Inc. (268600)
Dividendenrendite (TTM) von Cellivery Therapeutics, Inc. (Aktienkürzel: 268600) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Cellivery Therapeutics, Inc. (268600) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH